We are looking forward to our next curATalk by Prof Stefan Engelhard, the speaker of the CNATM Cluster (Cluster for Nucleic Acid Therapeutics Munich). Prof Engelhard will talk about "Macrophage-targeted RNA therapeutics" on January 15th, at 5 pm.

Prof Engelhardt is the director of the Institute of Pharmacology andToxicology at the Technical University of Munich. His research focuses on therapeutics for cardiovascular diseases. The cluster CNATM is like curATime a BMBF funded “Clusters4Future”. CNATM aims to develop novel nucleic acid-based drugs and next-generation vaccines.

‌

Click here to join the virtual lecture via MS Teams.

‌

curATime - Cluster for Atherothrombosis and Individualized Medicine - is our collaborative cluster for future which we initiated with the University Medical Center Mainz, the German Research Center for Artificial Intelligence (DFKI) and many more partners. The cluster is initially funded by the BMBF for three years. Within curATime, we want to reduce the incidence and impact of cardiovascular diseases, which is the leading cause of death worldwide.

Read more about curATime on www.curatime.org